Detailed Study Notes on DNA RNA Probes and Monoclonal Antibodies

DNA and RNA Probes in Biotechnology

In the field of biotechnology, a probe is defined as a single-stranded DNA or RNA fragment that has been either fluorescently or radioactively labeled. These probes are of variable length, typically ranging from $100$ to $1000$ bases long. The primary use of these probes is within DNA or RNA samples to detect the presence of specific nucleotide sequences that are perfectly complementary to the sequence contained in the probe itself. Because of their ability to bind with such specificity through matching complementary sequences, these probes have become vital tools for clinicians and researchers. They are widely utilized in the diagnosis of a diverse array of viral and bacterial diseases, offering a molecular-level confirmation of the presence of pathogens.

Diagnosis of Diseases Caused by Protozoa and Helminths

Biotechnology has introduced highly sensitive tools such as monoclonal antibodies and DNA probes to improve the diagnosis of diseases resulting from protozoa and helminths. These tools offer significant advantages over conventional diagnostic methods. For instance, monoclonal antibodies allow for the use of serological tests. These tests are exceptionally fast, often providing results within a matter of minutes. In contrast, conventional diagnostic methods can require several weeks to complete because they often depend on the culturing of the suspected bacteria or viruses to reach detectable levels, a process seen in the diagnosis of the Herpes virus.

DNA probes are described as being even more sensitive than monoclonal antibodies. While the diagnostic process using DNA probes takes longer than a rapid serological test, it typically requires only a few hours, which is still a massive improvement over the weeks required by traditional culture-based methods. Today, readymade DNA probes are being prepared for a variety of targets, including the Herpes virus as well as other human, animal, and plant viruses. Furthermore, probes are now commercially available for a significant number of human parasites within the protozoa and helminths categories, streamlining the identification of these infections in clinical settings.

Characteristics and Utility of Monoclonal Antibodies

The natural response of the immune system to any antigen, even one with a simple structure, is inherently polyclonal. This means the immune system produces a wide range of antibodies that possess different structures in both their binding regions and their effector regions. Monoclonal antibodies (mAb), however, are distinct because they represent a group of identical antibodies. This uniformity is achieved because they are produced by identical immune cells that are all direct clones of a unique parent cell.

Because it is possible to produce monoclonal antibodies that bind specifically to almost any given substance, they have become an indispensable tool in the fields of biochemistry, molecular biology, and medicine. Beyond their therapeutic use in protecting against diseases, monoclonal antibodies serve critical diagnostic roles. They are used to identify a wide variety of illnesses and can detect the presence of drugs, viral products, bacterial products, and other abnormal or unusual substances within the blood. Furthermore, they are used as a means to purify specific substances in laboratory settings.

Production of Monoclonal Antibodies

Monoclonal antibodies are typically produced using a sophisticated technique known as somatic cell hybridization. The process involves the fusion of two different types of cells: myeloma cells and spleen cells. Myeloma cells are a type of cancerous B-lymphocyte, which provides the resulting hybrid cell with the trait of immortality, allowing it to divide indefinitely. These myeloma cells are fused with spleen cells taken from a mouse that has been previously immunized with a specific desired antigen. The resulting hybridomas inherit the specific antibody-producing capability of the spleen cells and the longevity of the myeloma cells, allowing for the continuous production of identical antibodies targeted at the original antigen.